Publicaciones en colaboración con investigadores/as de Corporació Sanitària Parc Taulí (3)

2015

  1. First-line single-agent panitumumab in frail elderly patients with wild-type KRAS metastatic colorectal cancer and poor prognostic factors: A phase II study of the Spanish cooperative group for the treatment of digestive tumours

    European Journal of Cancer, Vol. 51, Núm. 11, pp. 1371-1380

2012

  1. Phase II open-label study of erlotinib in combination with gemcitabine in unresectable and/or metastatic adenocarcinoma of the pancreas: Relationship between skin rash and survival (Pantar study)

    Annals of Oncology, Vol. 23, Núm. 7, pp. 1919-1925

2009

  1. Recommendations on current approach to gastric cancer

    Clinical and Translational Oncology, Vol. 11, Núm. 8, pp. 518-525